Economic_NewsAstraZeneca wins shareholder approval for New York listing Rutt ontrd2 months ago01 mins Post Views: 88 Move by FTSE’s biggest company gains support of 99% of shareholders who voted in blow to London market 0 Reviews Post navigation Previous: AstraZeneca wins vote to press ahead with New York listingNext: Gold Price Forecast: XAU/USD failing to retain $4,000 amid broad US Dollar demand
Economist Mark Zandi sees the Fed surprising with three rate cuts in first half of 2026 Rutt ontrd39 minutes ago 0